6 completed, 2 active not recruiting, 1 recruiting, 1 unknown. 10 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 6, Active not recruiting 2, Recruiting 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow Yellow Fever: new trials by email Literature Review of Yellow Fever trials Research Report on Yellow Fever
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination 17D - Yellow Fever, Immunization; Infection | Phase 1 / Phase 2 | Recruiting | Oregon Health and Science University | 35 | 2023-08-01 | 2025-07-31 |
| An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity Stamaril, Imojev, Ixiaro - Infectious Disease, Yellow Fever | Phase 2 | Unknown | Singapore General Hospital | 70 | 2022-09-28 | 2023-04-12 |
| Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection Metformin Hydrochloride, Calcium and Vitamin D - Endoplasmic Reticulum Stress, Viral Infection | Phase 2 | Completed | Singapore General Hospital | 32 | 2021-10-22 | 2024-04-17 |
| Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia Yellow fever vaccine (produced on serum-free Vero cells), Yellow fever vaccine - Yellow Fever | Phase 2 | Active not recruiting | Sanofi Pasteur, a Sanofi Company | 690 | 2021-10-07 | 2026-06-01 |
| Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA Yellow fever vaccine (produced on serum-free Vero cells), Yellow fever vaccine - Yellow Fever, Healthy Volunteers | Phase 2 | Active not recruiting | Sanofi Pasteur, a Sanofi Company | 568 | 2021-07-01 | 2026-09-03 |
| The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination Yellow Fever Vaccine - Yellow Fever | Phase 1 / Phase 2 | Completed | University of Minnesota | 43 | 2020-07-01 | 2025-10-07 |
| Yellow Fever Vaccine on Statin/ Non Statin Subjects Stamaril (live attenuated yellow fever vaccine) - Yellow Fever Vaccine, Yellow Fever | Phase 2 | Completed | Singapore General Hospital | 37 | 2017-03-08 | 2020-03-23 |
| The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans Japanese Encephalitis vaccine, Yellow Fever vaccine - Yellow Fever, Encephalitis, Japanese | Phase 2 | Completed | Singapore General Hospital | 84 | 2013-10-01 | 2016-04-20 |
| Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus, Yellow Fever - Dengue, Dengue Fever | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 390 | 2011-12-06 | 2022-03-24 |
| Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®) Live attenuated Japanese encephalitis virus; Yellow fever virus, Yellow fever virus; Live attenuated Japanese encephalitis virus - Japanese Encephalitis, Yellow Fever | Phase 2 | Completed | Sanofi | 108 | 2004-07-01 | 2012-09-20 |
Encephalitis, Japanese (3) · Virus Diseases (2) · Communicable Diseases (1) · Dengue (1) · Infections (1) · Severe Dengue (1)
Arbovirus Infections (10) · Flaviviridae Infections (10) · Flavivirus Infections (10) · Hemorrhagic Fevers, Viral (10) · Mosquito-Borne Diseases (10) · RNA Virus Infections (10) · Vector Borne Diseases (10) · Infections (9) · Virus Diseases (8) · Brain Diseases (3) · Central Nervous System Diseases (3) · Central Nervous System Infections (3) · Central Nervous System Viral Diseases (3) · Encephalitis (3) · Encephalitis, Arbovirus (3)
Yellow Fever Vaccine (5) · Calcium (1) · Japanese Encephalitis Vaccines (1) · Metformin (1) · Vitamin D (1)
Singapore General Hospital (4) · Sanofi Pasteur, a Sanofi Company (3) · Oregon Health and Science University (1) · Sanofi (1) · University of Minnesota (1)
Singapore (5) · United States (4) · Australia (1) · Finland (1) · France (1) · Germany (1) · Spain (1) · Thailand (1) · Uganda (1)
Jenny Dr Low (1) · Jenny GH Low, MRCP (UK) (1) · Jenny Low Guek Hong (1) · Shirin Kalimuddin, MRCP (UK) (1) · Timothy Schacker, MD (1) · William Messer, MD PhD (1)
PMID 20864814, PMID 25872531, PMID 30241510, PMID 36969244, PMID 39794472, PMID 41950474
U01AI141981 (1)